Events
- July 14, 2008
2008 Q2 Earnings Announcement and Webcast
- July 6 - 11, 2008
Poster Presentation at a Gordon Research Conference
- May 21, 2008
Lloyd Segal, Thallion’s CEO, speaks about the future of the Canadian biotech sector on the Business News Network.
News
- July 10, 2008
Thallion Announces 2008 Second Quarter Results
- July 7, 2008
Notice of Thallion Pharmaceuticals Fiscal 2008 Second Quarter Conference Call
- June 26, 2008
Thallion receives health canada approval to initiate Phase II study for TLN-232 in metastatic melanoma patients- Company initiates Phase II study with its second oncology product -